Načítá se...
Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research
Use of placebo-controlled trials in medical and psychiatric research has been controversial, although a consensus is emerging about conditions under which placebo-controlled trials are ethical. In schizophrenia research, the paradigm of slow onset of antipsychotic effects has led to a model in which...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2632413/ https://ncbi.nlm.nih.gov/pubmed/18184634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbm152 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|